Professor Denis Kinane BDS FDSRCS PhD FDSRCPS has worked in academia for 35 years serving in various capacities at five universities in Europe and the USA.  His research specialisation is in clinical research, molecular genetics, cell biology, pathology and immunology.

He was at The University of Pennsylvania (UPENN) for 9 years, serving as Professor in Periodontics, Pathology and ENT at the Perelman School of Medicine at UPENN and Dean at UPENN Dental School. Prior to that, he was Research Dean at the University of Louisville for 7 years and held the same position at the University of Glasgow for 14 years.   He is currently a Professor at the University of Bern, Switzerland.

He is editor of a Springer Nature Journal. He has more than 240 peer-reviewed papers and more than 100 chapters, 84 articles and scholarly contributions, and innumerable presentations nationally and globally. His current research is in modifying the inflammatory response in chronic inflammation via genetic (CRISPR) manipulation of cell cytokines, receptors, signaling, transcription and epigenetics.

Professor Kinane sits on the board of two clinical companies plus biotechs in the US, China and Taiwan. He has advised various US and European companies and universities on Technology Transfer, QS World Ranking, Strategy and Research and Enterprise at Edinburgh, Geneva and Bangkok. He has also worked with a number of companies including serving on the Executive Boards of Penn Innovation, the LDI Health Business Institute, Wharton China, and Mid-Atlantic Health LLC. 

Most recently, he co-founded Cignpost Diagnostics Ltd where he also serves as Chief Medical Officer.